6 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... DVT = deep vein ... #Cancer #Algorithm ... #Anticoagulation ... #Management #Hematology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
and incidental DVT ... DOAC, direct oral ... #Cancer #Algorithm ... #Anticoagulation ... #Management #Hematology
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
Consensus 2019: Duration ... Thrombophilia • Cancer ... Bloodman #VTE #anticoagulation ... #duration #management ... #DVT #hematology
Heparin Induced Thrombocytopenia (HIT) - Diagnosis and Management - GrepMed Handbook

Presentation: 
 • Plts ↓50% (nadir
5-10d, venous (DVT ... heparin-PF4 complex → plt ... , Bivalirudin, DOAC ... • A/C Duration ... #Treatment #Hematology
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Thromboembolism Treatment Algorithm ... Isolated distal DVT ... Unprovoked proximal DVT ... #management #hematology ... #anticoagulation
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
MI, stroke, DVT/ ... ET-associated mutation ... • Treatment algorithms ... Hydroxyurea + anticoagulation ... #diagnosis #management